ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $492,000 | -7.7% | 39,602 | +1.9% | 0.01% | -12.5% |
| Q3 2016 | $533,000 | +85.7% | 38,875 | 0.0% | 0.01% | +60.0% |
| Q2 2016 | $287,000 | +0.7% | 38,875 | -12.9% | 0.01% | 0.0% |
| Q1 2016 | $285,000 | -5.6% | 44,625 | -7.8% | 0.01% | -16.7% |
| Q4 2015 | $302,000 | +16.2% | 48,403 | +8.8% | 0.01% | +20.0% |
| Q3 2015 | $260,000 | -33.0% | 44,486 | -5.2% | 0.01% | -28.6% |
| Q2 2015 | $388,000 | +2.6% | 46,908 | +2.4% | 0.01% | 0.0% |
| Q1 2015 | $378,000 | +16.7% | 45,808 | -2.7% | 0.01% | 0.0% |
| Q4 2014 | $324,000 | +32.2% | 47,058 | +3.7% | 0.01% | 0.0% |
| Q3 2014 | $245,000 | +142.6% | 45,358 | +186.3% | 0.01% | +133.3% |
| Q2 2014 | $101,000 | -65.1% | 15,842 | -55.9% | 0.00% | -62.5% |
| Q1 2014 | $289,000 | +26.2% | 35,889 | +6.8% | 0.01% | +14.3% |
| Q4 2013 | $229,000 | +27.9% | 33,592 | +245.3% | 0.01% | +16.7% |
| Q3 2013 | $179,000 | +4.7% | 9,727 | -0.2% | 0.01% | 0.0% |
| Q2 2013 | $171,000 | – | 9,747 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |